These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes. Eue I, Kumar R, Dong Z, Killion JJ, Fidler IJ. J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196 [Abstract] [Full Text] [Related]
3. Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002. Shinohara H, Bucana CD, Killion JJ, Fidler IJ. J Immunother; 2000 Sep; 23(3):321-31. PubMed ID: 10838661 [Abstract] [Full Text] [Related]
6. Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium. Shinohara H, Killion JJ, Bucana CD, Yano S, Fidler IJ. Clin Cancer Res; 1999 Aug; 5(8):2148-56. PubMed ID: 10473099 [Abstract] [Full Text] [Related]
7. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ. Cancer Res; 1995 Jul 15; 55(14):3123-31. PubMed ID: 7541713 [Abstract] [Full Text] [Related]
8. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C, Loher F, Zang C, Ismair MG, Petrides PE. Clin Cancer Res; 1999 May 15; 5(5):1115-24. PubMed ID: 10353746 [Abstract] [Full Text] [Related]
9. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis. Lafuma C, El Nabout RA, Crechet F, Hovnanian A, Martin M. J Invest Dermatol; 1994 Jun 15; 102(6):945-50. PubMed ID: 8006459 [Abstract] [Full Text] [Related]
10. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. Xie B, Dong Z, Fidler IJ. J Immunol; 1994 Apr 01; 152(7):3637-44. PubMed ID: 8144939 [Abstract] [Full Text] [Related]
14. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. Zhang Y, McCluskey K, Fujii K, Wahl LM. J Immunol; 1998 Sep 15; 161(6):3071-6. PubMed ID: 9743373 [Abstract] [Full Text] [Related]
15. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR. Oncol Res; 1993 Sep 15; 5(1):19-28. PubMed ID: 8369572 [Abstract] [Full Text] [Related]
16. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G. Int J Cancer; 1995 Aug 09; 62(4):407-13. PubMed ID: 7635566 [Abstract] [Full Text] [Related]
17. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK. J Cell Physiol; 1993 Dec 09; 157(3):644-9. PubMed ID: 8253876 [Abstract] [Full Text] [Related]